a Phase 2b clinical trial of MAR001
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs MAR-001 (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 15 Jan 2025 New trial record
- 09 Jan 2025 According to Marea Therapeutics media release, Based on positive results from Phase 2a study trial, company preparing to advance MAR001 into Phase 2b clinical development in the first half of 2025.